Revised SPC: Idelvion (albutrepenonacog alfa) powder and solvent for solution for injection- all strengths

Source:
electronic Medicines Compendium - eMC
Publisher:
electronic Medicines compendium
Publication date:
30 October 2019

Abstract

SPC updated to include statement that formation of inhibitor to factor IX has been reported during factor replacement therapy with Idelvion in the treatment of haemophilia B.